Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease (Q48650878)

13 February 2018

title

Cerebrospinal fluid profiles of amyloid β-related biomarkers in Alzheimer's disease (English)

1 reference

13 February 2018

0 references

1 reference

8

Henrik Zetterberg

1 reference

13 February 2018

7

Kaj Blennow

1 reference

13 February 2018

5

Lennart Minthon

1 reference

13 February 2018

3

Niklas Mattsson

1 reference

13 February 2018

Ulf Andreasson

2

object named as

Ulf Andreasson

1 reference

13 February 2018

Jan Marcusson

4

object named as

Jan Marcusson

1 reference

13 February 2018

author name string

Christoffer Rosén

1

1 reference

13 February 2018

Niels Andreasen

6

1 reference

13 February 2018

publication date

18 February 2012

1 reference

13 February 2018

published in

NeuroMolecular Medicine

1 reference

13 February 2018

volume

14

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

page(s)

65-73

1 reference

13 February 2018

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Tau protein in cerebrospinal fluid: a biochemical marker for axonal degeneration in Alzheimer disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Longitudinal stability of CSF biomarkers in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Endocytosis is required for synaptic activity-dependent release of amyloid-beta in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Comparison of analytical platforms for cerebrospinal fluid measures of β-amyloid 1-42, total tau, and p-tau181 for identifying Alzheimer disease amyloid plaque pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Amyloid and tau cerebrospinal fluid biomarkers in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Detection of beta-endorphin in the cerebrospinal fluid after intrastriatal microinjection into the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Increased beta-Secretase activity in cerebrospinal fluid of Alzheimer's disease subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Expression and activity of beta-site amyloid precursor protein cleaving enzyme in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Neuroinflammation in Lyme neuroborreliosis affects amyloid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Gamma-secretase-dependent amyloid-beta is increased in Niemann-Pick type C: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Robust central reduction of amyloid-β in humans with an orally available, non-peptidic β-secretase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Simultaneous measurement of beta-amyloid(1-42), total tau, and phosphorylated tau (Thr181) in cerebrospinal fluid by the xMAP technology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

CSF soluble amyloid precursor proteins in the diagnosis of incipient Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Alzheimer's disease: synaptic dysfunction and Abeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Soluble beta-amyloid precursor protein is related to disease progression in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Detection of a soluble form of BACE-1 in human cerebrospinal fluid by a sensitive activity assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Elevated cerebrospinal fluid BACE1 activity in incipient Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

OPLS discriminant analysis: combining the strengths of PLS-DA and SIMCA classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12017-012-8171-4

Novel mutations introduced at the beta-site of amyloid beta protein precursor enhance the production of amyloid beta peptide by BACE1 in vitro and in cells.

21 January 2018

1 reference

12 December 2020

Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease

1 reference

12 December 2020

Cerebrospinal fluid biomarkers for Alzheimer’s disease: diagnostic performance in a homogeneous mono-center population

1 reference

12 December 2020

In-office mental status testing: a practical guide.

1 reference

12 December 2020

10.1007/S12017-012-8171-4

Identifiers

DOI

1 reference

13 February 2018

1 reference

13 February 2018